Journal of General Internal Medicine

, Volume 13, Issue 1, pp 1–8 | Cite as

Smoking cessation among inner-city African Americans unsing the nicotine transdermal patch

  • Jasjit S. Ahluwalia
  • Sally E. Mcnagny
  • W. Scott Clark
Original Articles


OBJECTIVE: To determine the efficacy of the transdermal nicotine patch for smoking cessation in inner-city African Americans.

DESIGN: Double-blind, placebo-controlled, randomized trial.

SETTING: Outpatient in an inner-city hospital.

PATIENTS AND PARTICIPANTS: A computer-generated random numbers table with a block size set at 20 was used to randomize 410 patients to one of two study arms.

INTERVENTIONS: The transdermal nicotine patch for 10 weeks as an adjunct to brief counseling.

MEASUREMENTS AND MAIN RESULTS: Of the 410 patients randomized, mean age was 48 years, 65% were female, 41% had less than a high school education, 51% had an annual household income of less than $8,000, and the average number of cigarettes smoked per day was 20. Quit rates at 10 weeks were 21.5% (44/205) with the nicotine patch, and 13.7% (28/205) with the placebo patch (p=.03). At 6 months, quit rates were 17.1% (35/205) with the nicotine patch, and 11.7% (24/205) with the placebo patch (p=.08). After adjusting for baseline differences in age and educational attainment, differences remained significant at 10 weeks (p=.04), but were not significant at 6 months (p=.14). Compliance rates for return visits were 83%, 78%, 55%, and 52%, at 1, 2, 6, and 10 weeks, respectively.

CONCLUSIONS: The nicotine patch significantly improves short-term quit rates in inner-city African Americans who are interested in trying to quit smoking. Efforts should be made to reach underserved populations through smoking cessation programs, and to assist in maintaining abstinence.

Key words

smoking cessation African Americans innercity patients nicotine patch 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207–12.PubMedCrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control. Cigarette smoking among adults—United States, 1993. MMWR. 1994;43:925–30.Google Scholar
  3. 3.
    Center for Disease Control. African Americans and smoking. Centers for Disease Control—At A Glance.Google Scholar
  4. 4.
    Givino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev. 1995;17:48–65.Google Scholar
  5. 5.
    Hahn LP, Folsom AR, Sprafka JM, Norsted SW. Cigarette smoking and cessation behaviors among urban blacks and whites. Public Health Rep. 1990;105:290–5.PubMedGoogle Scholar
  6. 6.
    Ahluwalia JS, McNagny SE. Smoking prevalence and desire to quit in inner-city African-American walk-in clinic patients. Clin Res. 1993;41:752A.Google Scholar
  7. 7.
    Resnicow K, Futterman R, Weston RW, et al. Smoking prevalence of Harlem residents: baseline results from the Harlem Health Connection Project. Am J Health Promot. 1996;10:343–6.PubMedGoogle Scholar
  8. 8.
    Office on Smoking and Health. Adult Use of Tobacco. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service; 1989: PHS publication 90-2004.Google Scholar
  9. 9.
    U.S. Dept. of Health and Human Services. Reducing the Health Consequences of Smoking: 25 years of Progress. A Report of the Surgeon General. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. DHHS publication (CDC) 89-8411.Google Scholar
  10. 10.
    U.S. Dept. Health and Human Services. The Health Benefits of Smoking Cessation. U.S. Dept. Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990. DHHS publication (CDC) 90–8416.Google Scholar
  11. 11.
    Martin R, Commings SR, Coates TJ. Ethnicity and smoking: differences in white, black, Hispanic and Asian. AM J Prev Med. 1990;6:194–9.Google Scholar
  12. 12.
    Novotny TE, Warner KE, Kendrick JS, Remington PL. Smoking by blacks and whites: socioeconomic and demographic differences. Am J Public Health. 1988;78:1187–9.PubMedGoogle Scholar
  13. 13.
    Centers for Disease Control. Smoking cessation during previous year among adults—United States, 1990 and 1991. MMWR. 1993;42:504–7.Google Scholar
  14. 14.
    Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physician’s smoking cessation counseling. JAMA. 1996;275:1247–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. JAMA. 1994;27:1940–7.CrossRefGoogle Scholar
  16. 16.
    Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994;343:139–42.PubMedCrossRefGoogle Scholar
  17. 17.
    Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ. 1994;308:21–6.PubMedGoogle Scholar
  18. 18.
    Wasley MA, McNagny SE, Ahluwalia JS, Phillips VL. The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med. 1997;26:264–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Fiore MC, Bailey WC, Cohen SJ, et al. Smoking Cessation: Iformation for Specialists. Clinical Practice Guideline. Quick Reference Guide for Smoking Cessation Specialists, No. 18. Rockvill, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Centers for Disease Control and Prevention; 1996.Google Scholar
  20. 20.
    Williams MV, Parker RM, Baker DW, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA. 1995;274:1677–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Gorsline J, Gupta SK, Dye D, Rolf CN. Nicotine dose relationship for Nicoderm (nicotine transdermal system) at steady state. Pharmacol Res. 1991;10 (suppl):S299.Google Scholar
  22. 22.
    Robinson RG, Orleans CT, James DA, Sutton CD. Pathways to Freedom: Winning the Fight Against Tobacco. Philadelphia, Pa: Fox Chase Center; 1992.Google Scholar
  23. 23.
    Marion Merrill Dow Inc. The 6-2-2 Committed Quitter’s Program: Nicoderm (Nicotine Transdermal System). Kansas City, Mo: Marion Merrill Dow Inc.; 1993.Google Scholar
  24. 24.
    Duelberg SI. Preventive health behavior among black and white women in urban and rural areas. Soc Sci Med. 1992:34:191–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Orleans CT, Schoenbach VJ, Salmon MA, et al. A survey of smoking and quitting patterns among black Americans. Am J Public Health. 1989;79:176–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159–82.PubMedCrossRefGoogle Scholar
  27. 27.
    Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119–27.PubMedCrossRefGoogle Scholar
  28. 28.
    Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons; 1989.Google Scholar
  29. 29.
    Abelin T, Ehrsam R, Buhler-Reichert A, Imhof PR, Muller P, Thommen A. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol. 1989;11:205–14.PubMedGoogle Scholar
  30. 30.
    Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest. 1994;105:524–33.PubMedGoogle Scholar
  31. 31.
    Richmond RL, Harris K, Neto A. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Med J Aust. 1994;161:130–5.PubMedGoogle Scholar
  32. 32.
    Tonnesen P, Norregaard J, Simonsen K, Sawa U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991;325:311–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Romano PS, Bloom J, Syme SL. Smoking, social support, and hassles in an urban African-American community. Am J Public Health. 1991;81:1415–22.PubMedGoogle Scholar
  34. 34.
    Delongis A, Coyne J, Dakof G, Folkman S, Lazarus R. Relationship of daily hassles, uplifts, and major life events to health status. Health Psychol. 1982;1:119–36.CrossRefGoogle Scholar
  35. 35.
    Robinson RG, Pertschuk JD, Sutton C. Smoking and African Americans. In: Samuels SE, Smith MD, eds. Improving the Health of the Poor—Strategies for Prevention. Menlo Park, Calif: The Henry J. Kaiser Family Foundation; 1992.Google Scholar
  36. 36.
    Short PF, Cornelius LJ, Goldstone DE. Health insurance of minorities in the United States. J Health Care Poor Underserved. 1990;1:9–24.PubMedGoogle Scholar
  37. 37.
    National Cancer Institute. Cancer Prevention Awareness Survey Wave II: Management Summary. Bethesda, Md: Office of Cancer Communications, National Cancer Institute, National Institutes of Health; 1987.Google Scholar
  38. 38.
    Daughton DM, Heatley SA, Prendergast JJ, et al. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy—a randomized, placebo-controlled, doubleblind study. Arch Intern Med. 1991;151:749–52.PubMedCrossRefGoogle Scholar
  39. 39.
    Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation—six-month results from two multicenter controlled clinical trials. JAMA. 1991;266:3133–8.CrossRefGoogle Scholar
  40. 40.
    Hurt RD, Dale LC, Frederickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. JAMA. 1994;271:595–600.PubMedCrossRefGoogle Scholar
  41. 41.
    Fiore MC, Jorenby DE, Baker TB, Kenford SL. Tobacco dependence and the nicotine patch. JAMA. 1992;268:2687–94.PubMedCrossRefGoogle Scholar
  42. 42.
    Glynn TJ, Boyd GM, Gruman JC. Essential elements of self-help/minimal intervention strategies for smoking cessation. Health Educ Q. 1990;17:329–45.PubMedGoogle Scholar
  43. 43.
    Glynn TJ, Boyd GM, Gruman JC. Self-Guided Strategies for Smoking Cessation: A Program Planner’s Guide. Bethesda, Md: Smoking and Tobacco Control Program, National Center Institute, USDHHS; 1990.Google Scholar
  44. 44.
    U.S. Dept. of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. Washington, DC: U.S. Dept. of Health and Human Services; 1988. DHHS publication (CDC) 88–8406.Google Scholar
  45. 45.
    Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51:390–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Voorhees CC, Stillman FA, Swank RT, Heagerty PJ, Levine DM, Becker DM. Heart, body and soul: impact of church-based smoking cessation interventions on readiness to quit. Prev Med. 1996;25:277–85.PubMedCrossRefGoogle Scholar
  47. 47.
    U.S. Dept. of Health and Human Services. Healthy People 2000: Midcourse Review and 1995 Revisions. Washington, DC: Government Printing Office; 1995.Google Scholar

Copyright information

© Society of General Internal Medicine 1998

Authors and Affiliations

  • Jasjit S. Ahluwalia
    • 1
  • Sally E. Mcnagny
    • 1
  • W. Scott Clark
    • 2
  1. 1.Received from the Department of MedicineEmory University School of MedicineAtlanta
  2. 2.the Department of BiostatisticsRollins School of Public HealthAltanta
  3. 3.Department of Preventive Medicine and Internal MedicineUniversity of Kansas Medical CenterKansas City

Personalised recommendations